Sign up
Pharma Capital

LeanLife Health to raise C$1mln from placing

LeanLife delivers high concentration levels of omega-3 as a nutritional additive, it said
LeanLife Health to raise C$1mln from placing
Omega 3 is important for human health

Nutritional additive and ingredients group LeanLife Health Inc. (CSE:LLP) is set to raise C$1mln via a private placing to be used for working capital.

It will consist of 20mln units at C$0.05 each for total gross proceeds of C$1mln.

READ: LeanLife Health poised for production at new plant once permits are in place

Each unit will consist of one share and one transferable share purchase warrant, which is exercisable into one further share at a price of C$0.075 per share for three years from closing.

The proceeds of the placing will be used for the company's general working capital.

LeanLife delivers high concentration levels of omega-3 as a nutritional additive. Its products are for use in commercial food processing.

Last month, it updated on its manufacturing capability, revealing that the main equipment had been purchased and delivered to the new facility in Canada.

It is still awaiting the approval of permits to operate, but once in place will begin production immediately.

The group's products are extracted from flaxseeds, a plentiful and non-animal source of omega-3.

Such products will include ingredients for making and/or fortifying commercial foods such as bread, noodles, juices, yogurt and cheese.

Shares are at C$0.055 at the time of writing.


Register here to be notified of future LLP Company articles
View full LLP profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.